Dermatomyositis (DM) is also an autoimmune disease, in which characteristic autoantibodies such as anti-MDA5, anti-Jo-1, and anti-TIF1γ are involved in its pathogenesis, each presenting a different clinical picture [10,11,12]. This evidence concerns the gene TRIM33 and dermatomyositis.